DioScor Platform Development

About ConsoneAI

ConsoneAI is a pioneering London-based TechBio startup applying artificial intelligence to de-risk and accelerate drug discovery through advanced toxicity prediction. Its flagship product, DioScor, utilizes bespoke deep learning models trained on a vast, curated database of over 80,000 chemical compounds to forecast toxicological outcomes across species and specific demographics. The company aims to address the high failure rate of drug candidates due to safety issues, support the industry's 3Rs (Reduce, Replace, Refine) commitment to animal welfare, and streamline regulatory submissions. Founded by a team with pharmaceutical industry experience, ConsoneAI positions itself at the intersection of ethical innovation and computational efficiency in preclinical development.